Literature DB >> 20043106

Analysis of loss of heterozygosity on chromosome 4q in hepatocellular carcinoma using high-throughput SNP array.

Huakun Zhang1, Haiqing Ma, Qijing Wang, Minshan Chen, Desheng Weng, Hui Wang, Jun Zhou, Yongqiang Li, Jiancong Sun, Yibing Chen, Xiaoting Liang, Jingjing Zhao, Ke Pan, Huiyun Wang, Jianchuan Xia.   

Abstract

To identify tumour suppressor genes (TSGs) associated with hepatocellular carcinoma (HCC) on chromosome 4q using a high-throughput single nucleotide polymorphism (SNP) array, we first scanned for loss of heterozygosity (LOH) of 40 SNPs on chromosome 4q and discovered 2 hot regions: 4q24-26 and 4q34.3-35. We then further scanned for LOH of 338 SNPs in genes around 4q34.3-35 and discovered 3 genes with the most frequent LOH: nei endonuclease VIII-like 3 (NEIL3), interferon regulatory factor 2 (IRF2) and inhibitor of growth family member 2 (ING2). A review of the literature indicates only ING2 might be a TSG associated with HCC.

Entities:  

Mesh:

Year:  2010        PMID: 20043106

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  12 in total

1.  An autoinhibitory role for the GRF zinc finger domain of DNA glycosylase NEIL3.

Authors:  Alyssa A Rodriguez; Jessica L Wojtaszek; Briana H Greer; Tuhin Haldar; Kent S Gates; R Scott Williams; Brandt F Eichman
Journal:  J Biol Chem       Date:  2020-09-02       Impact factor: 5.157

Review 2.  Neil3, the final frontier for the DNA glycosylases that recognize oxidative damage.

Authors:  Minmin Liu; Sylvie Doublié; Susan S Wallace
Journal:  Mutat Res       Date:  2012-12-26       Impact factor: 2.433

Review 3.  ING1 and ING2: multifaceted tumor suppressor genes.

Authors:  Claire Guérillon; Delphine Larrieu; Rémy Pedeux
Journal:  Cell Mol Life Sci       Date:  2013-02-15       Impact factor: 9.261

4.  Extensive analysis of D7S486 in primary gastric cancer supports TESTIN as a candidate tumor suppressor gene.

Authors:  Haiqing Ma; Desheng Weng; Yibing Chen; Wei Huang; Ke Pan; Hui Wang; Jiancong Sun; Qijing Wang; Zhiwei Zhou; Huiyun Wang; Jianchuan Xia
Journal:  Mol Cancer       Date:  2010-07-13       Impact factor: 27.401

5.  Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo.

Authors:  Phyllis Fung-Yi Cheung; Chi Wai Yip; Linda Wing-Chi Ng; Kwok Wai Lo; Nathalie Wong; Kwong Wai Choy; Chit Chow; Kui Fat Chan; Tan To Cheung; Ronnie Tung-Ping Poon; Sheung Tat Fan; Siu Tim Cheung
Journal:  Cancer Cell Int       Date:  2014-10-09       Impact factor: 5.722

Review 6.  Genetic alterations in hepatocellular carcinoma: An update.

Authors:  Zhao-Shan Niu; Xiao-Jun Niu; Wen-Hong Wang
Journal:  World J Gastroenterol       Date:  2016-11-07       Impact factor: 5.742

Review 7.  Exploiting ING2 Epigenetic Modulation as a Therapeutic Opportunity for Non-Small Cell Lung Cancer.

Authors:  Alice Blondel; Amine Benberghout; Rémy Pedeux; Charles Ricordel
Journal:  Cancers (Basel)       Date:  2019-10-21       Impact factor: 6.639

8.  A novel signature based on microvascular invasion predicts the recurrence of HCC.

Authors:  Binbin Du; Fang Wang; Beers Jarad; Zhihui Wang; Yanzhou Zhang
Journal:  J Transl Med       Date:  2020-07-06       Impact factor: 5.531

9.  HERC5 is a prognostic biomarker for post-liver transplant recurrent human hepatocellular carcinoma.

Authors:  Feng Xue; Brandon W Higgs; Jiaqi Huang; Chris Morehouse; Wei Zhu; Xin Yao; Philip Brohawn; Zhan Xiao; Yinong Sebastian; Zheng Liu; Yun Xia; Dong Shen; Mike Kuziora; Zhengwei Dong; Hulin Han; Yi Gu; Jianren Gu; Qiang Xia; Yihong Yao
Journal:  J Transl Med       Date:  2015-12-11       Impact factor: 5.531

10.  Integrative Analysis of Microarray Data to Reveal Regulation Patterns in the Pathogenesis of Hepatocellular Carcinoma.

Authors:  Juan Chen; Zhenwen Qian; Fengling Li; Jinzhi Li; Yi Lu
Journal:  Gut Liver       Date:  2017-01-15       Impact factor: 4.519

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.